Literature DB >> 33575910

Multiple vertebral compression fractures in a human immunodeficiency virus-positive patient with glucocorticoid-induced Cushing syndrome treated with percutaneous vertebroplasty: a case report.

H-E Hsu1, Y-P Hsu1, C-H Yu2.   

Abstract

The authors present a rare case of multiple vertebral compression fractures in a young female with iatrogenic glucocorticoid-induced Cushing syndrome and concomitant human immunodeficiency virus (HIV) infection. Both long-term steroid use and HIV infection may lead to osteopenia or even osteoporosis. Multiple vertebral fractures in young patients are very uncommon and should alert the examiner to investigate any underlying cause. Treatment choices include pharmacological agents such as bisphosphonates or parathyroid hormone and even surgical interventions such as percutaneous vertebroplasty.

Entities:  

Keywords:  Cushing syndrome; Human immunodeficiency virus; Osteoporosis; Percutaneous vertebroplasty; Vertebral compression fracture

Mesh:

Substances:

Year:  2021        PMID: 33575910     DOI: 10.1007/s00198-021-05880-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  2 in total

1.  New fractures after vertebroplasty: adjacent fractures occur significantly sooner.

Authors:  A T Trout; D F Kallmes; T J Kaufmann
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

2.  [Clinical research of percutaneous vertebroplasty or percutaneous kyphoplasty for treating osteoporotic vertebral compression fractures induced by glucocorticosteroid].

Authors:  H L Sun; C D Li; J L Zhu; X D Yi; H Liu; H L Lu; H Li; Z R Yu; Y Wang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2015-04-18
  2 in total
  1 in total

1.  Analysis of the Effect of Percutaneous Cone Shaping in Patients with Osteoporotic Vertebral Fractures.

Authors:  Jiasheng Yu; Daobo Fan; Lei Bao; Dongqian Feng; Bin Zhang
Journal:  Contrast Media Mol Imaging       Date:  2022-08-09       Impact factor: 3.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.